首页> 外国专利> Agents for treating osteoporosis and inhibiting osteoclast formation

Agents for treating osteoporosis and inhibiting osteoclast formation

机译：用于治疗骨质疏松症和抑制破骨细胞形成的药物

页面导航

摘要
著录项
相似文献

摘要

Compositions and methods for treating osteoporosis, the formation of osteoeclasts, and/or for the suppression of decreasing spongy bone density. Example methods include administering Cordyceps sinensis or its processed product.

机译：用于治疗骨质疏松症，破骨细胞形成和/或抑制海绵状骨密度降低的组合物和方法。示例方法包括施用冬虫夏草或其加工产品。 展开▼

著录项

公开/公告号US7311919B2

专利类型

公开/公告日2007-12-25

原文格式PDF

申请/专利权人 SHIGETOSHI KADOTA;YOSHINOBU HASHIMOTO;CHIA-CHIN SHEU;
展开▼

申请/专利号US20060533665

发明设计人 SHIGETOSHI KADOTA;YOSHINOBU HASHIMOTO;CHIA-CHIN SHEU;
展开▼

申请日2006-09-20

分类号A61K36/068;A61P19/10;A61P3/14;

国家 US

入库时间 2022-08-21 20:09:30

相似文献

专利

外文文献

中文文献

1. 木豆素在抑制破骨细胞形成和预防骨质疏松症药物中的应用 [P] . 中国专利： CN107625759A . 2018-01-26

2. 骨质疏松症治疗剂及破骨细胞形成抑制剂 [P] . 中国专利： CN1541704A . 2004-11-03

3. Agents for treating osteoporosis and inhibiting osteoclast formation [P] . 美国专利： US7387781B2 . 2008-06-17

机译：用于治疗骨质疏松症和抑制破骨细胞形成的药物

4. Agents For Treating Osteoporosis And Inhibiting Osteoclast Formation [P] . 美国专利： US2007014811A1 . 2007-01-18

机译：用于治疗骨质疏松症和抑制破骨细胞形成的药物

5. Agents for treating osteoporosis and inhibiting osteoclast formation [P] . 美国专利： US2005013830A1 . 2005-01-20

机译：用于治疗骨质疏松症和抑制破骨细胞形成的药物

1. New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide [J] . Sakae Tanaka, Taiji Adachi, Tatsuhiko Kuroda, 骨研究（英文版） . 2014,第004期

2. New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide [J] . Sakae Tanaka, Taiji Adachi, Tatsuhiko Kuroda, 骨研究：英文 . 2014,第004期

3. Lrp1 in osteoblasts controls osteoclast activity and protects against osteoporosis by limiting PDGF–RANKL signaling [J] . Alexander Bartelt, Martin Dietrich, Jan P.Tuckermann, 骨研究（英文版） . 2018,第001期

4. Lrp1 in osteoblasts controls osteoclast activity and protects against osteoporosis by limiting PDGF–RANKL signaling [J] . Alexander Bartelt, Friederike Behler-Janbeck, F.Timo Beil, 骨研究：英文 . 2018,第001期

5. Curcumin Inhibits ROS Formation and Apoptosis in Methylglyoxal-Treated Human Hepatoma G2 Cells [C] . WEN-HSIUNG CHAN, HSIN-JUNG WU, YAN-DER HSUUW Asian Society for Mitochondrial Research and Medicine . 2005

6. Part I. Development of new organic synthetic methods: Palladium and copper catalyzed carbon-carbon, carbon-sulfur, carbon-nitrogen, and carbon-oxygen bond formation as well as DABCO-mediated stereospecific synthesis of acrylate ethers and amines. Part II. Design, synthesis and SAR studies of new classes of agents to treat drug-resistant bacteria, anthrax and tuberculosis infections. [D] . Kabir, Mohd Shahjahan. 2011

7. Reveromycin A an agent for osteoporosis inhibits bone resorption by inducing apoptosis specifically in osteoclasts [O] . Je-Tae Woo, Makoto Kawatani, Masanori Kato, 2006

8. Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts [O] . Woo, Je-Tae, Kawatani, Makoto, Kato, Masanori, 2006

9. Evaluation of Chemical Agents for Inhibiting Acid Mine Drainage Formation [R] . Nebgen, J. W. , Weatherman, D. F. 1979

1. Study and analysis on the mechanisms of action of cytokines on osteoclasts in osteoporosis [J] . Jin-Mei Zhang ,Yan Yin ,Xin-Qi Liu . TMR理论与假说 . 2020,第004期

2. 铝能够抑制破骨细胞形成和减弱破骨细胞骨吸收活性 [C] . 李丙云 ,裴俊瑞 ,高彦辉 . 第七次全国地方病学术会议 . 2011

3. 桃叶珊瑚苷通过抑制与Nrf2介导的抗氧化相关的破骨细胞分化来改善骨质疏松症的研究 [A] . 宋民凯 . 2021